Borealis Biosciences Overview

  • Status
  • Private

  • Employees
  • 25

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $150M

  • Investors
  • 2

Borealis Biosciences General Information

Description

Operator of a discovery-stage biotechnology company intended for developing next-generation xRNA-based medicines for kidney diseases. The company maps target opportunities across subsets of patients with kidney disease and defines methods to enhance the delivery of RNA medicines to specific cell types, enabling scientists to address major unmet needs for patients with kidney diseases.

Contact Information

Website
www.borealisbio.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Vancouver, British Columbia
  • Canada
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Biotechnology
Vertical(s)
Life Sciences
Corporate Office
  • Vancouver, British Columbia
  • Canada

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Borealis Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC (Series A) 22-Aug-2024 $150M Completed Startup
To view Borealis Biosciences’s complete valuation and funding history, request access »

Borealis Biosciences Executive Team (1)

Name Title Board Seat
Jerel Davis Ph.D Chairman
To view Borealis Biosciences’s complete executive team members history, request access »

Borealis Biosciences Board Members (1)

Name Representing Role Since
Jerel Davis Ph.D Self Chairman
To view Borealis Biosciences’s complete board members history, request access »

Borealis Biosciences Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Borealis Biosciences Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Novartis Corporation Minority
Versant Ventures Venture Capital Minority
To view Borealis Biosciences’s complete investors history, request access »

Ready to get started?

Request a free trial

Borealis Biosciences FAQs

  • Where is Borealis Biosciences headquartered?

    Borealis Biosciences is headquartered in Vancouver, Canada.

  • What is the size of Borealis Biosciences?

    Borealis Biosciences has 25 total employees.

  • What industry is Borealis Biosciences in?

    Borealis Biosciences’s primary industry is Discovery Tools (Healthcare).

  • Is Borealis Biosciences a private or public company?

    Borealis Biosciences is a Private company.

  • What is Borealis Biosciences’s current revenue?

    The current revenue for Borealis Biosciences is .

  • How much funding has Borealis Biosciences raised over time?

    Borealis Biosciences has raised $150M.

  • Who are Borealis Biosciences’s investors?

    Novartis and Versant Ventures have invested in Borealis Biosciences.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »